Epsilon M&A Deal Report - Laboratoires Delbert
Transaction Multiples for the Valuation of Private Companies
Private Group backed by Vivalto Partners / Laboratoires Delbert
No EMAT :
112600
Announced Date :
24/04/2023
Type :
SBO (Secondary Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private Group backed by Vivalto Partners
Target :
Laboratoires Delbert
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2002 by Marc Childs & Thierry Hoffmann , Laboratoires Delbert is a private and independent pharmaceutical. > Specialized in the acquisition and remise on the market of major therapeutic...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | |||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 20/12/2019 | Biolix | Analysis | France | *** | 112577 |
| 05/04/2018 | Biorhin | Proxilab | France | ** | 112569 |
Source: Epsilon Research / EMAT
